Carmichael is co‐founder and managing partner of Material Impact, a fund that builds resilient technology companies developing products to solve real‐world problems using innovative materials. He is also the co‐lead of the investment committee at Breakthrough Energy Ventures, a mission‐oriented group chaired by Bill Gates committed to creating and building companies that address climate change and the long‐term sustainability of the planet.
Prior to venture, as an entrepreneur, Carmichael built several successful companies that create innovative products by applying material science. His strategy as a venture investor is based on his successful career as an entrepreneur in materials innovation, blending a unique business model of licensing university technology and commercializing it through targeted partnerships with Fortune 500 companies.
Prior to his career as an investor, Carmichael co‐founded several ventures, in which he served as President and CEO or Chairman.
Prior to his entrepreneurial career, Carmichael worked in business development at GelTex Pharmaceuticals, acquired by Genzyme for $1.3 billion, and in new product and business development at Dow Chemical (formerly Union Carbide Corporation).
Elected to the Board of Trustees of Duke University in 2013, Carmichael currently serves as Vice Chairman. He was appointed to the Duke University Health System Board of Directors in 2017 and currently serves on the Audit and Compliance Committee.
Carmichael also serves on the boards for the Consumer Technology Association, WGBH, and Massachusetts General Hospital Physicians Organization. Carmichael was selected by the Aspen Institute to participate in the Finance Leaders Fellowship program as a senior leader in the venture capital industry.
Carmichael received his BS and PhD in organic chemistry from Duke University and completed his postdoctoral National Science Foundation fellowship at Harvard University. Carmichael also has an MBA from MIT Sloan School of Management.